Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 20 percent shareholding.

Through a recent directed issue, ShapeQ GmbH has acquired 1,404,081 shares which means a total holding of shares is 3,227,568 after the direct issue transaction, corresponding to approximately 20.9 percent of the votes and capital in Redsense Medical AB.

Contact information

For more information, please contact: 
Jennie Kardell, CEO
Telephone: +46 72-171 1264
E-mail: jennie.kardell (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862